The risk of major adverse events during the periprocedural period is roughly fourfold higher with CABG surgery than with PCI for left main coronary artery disease, but regardless of the initial ...
Clinical outcomes in patients with metastatic non-small cell lung cancer and head and neck squamous cell cancer treated with immune checkpoint inhibitors according to COVID-19 vaccination status.
Discovery of immune checkpoint inhibitors has revolutionized the therapeutic landscape for the treatment of cancer. Development of immunotherapy for cancer is based on modulation of T cell function ...
Pregnant women with symptomatic coronavirus disease 2019 (Covid-19) have a higher risk of adverse outcomes than do women who are not pregnant. 1,2 In part because of these findings, Covid-19 ...
Nearly 25% of hospital admissions included at least one adverse event, as indicated from data from 2809 admissions at 11 hospitals. The 1991 Harvard Medical Practice Study (HMPS), which focused on ...
Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...
Adverse event rates among hospitalized patients declined significantly from 2010 through 2019 in a large study of medical records for adults admitted for acute myocardial infarction, heart failure, ...
Benefits and Barriers of Technology for Home Function and Mobility Assessment: Perspectives of Older Patients With Blood Cancers, Caregivers, and Clinicians We developed methods for visualizing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results